GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th ...

The TIGIT inhibitors market is poised for growth with the anticipated drug approval by 2030, over 40 drugs in clinical trials, and a dynamic landscape involving major pharmaceutical and biotech firms.

Gilead Sciences has found a shiny new package for one of its cancer assets, inking a research pact worth up to $300 million ...

The deal hands Amgen a drug that destroys two proteins known to drive certain types of acute myeloid leukemia, a profile that ...

Chattering teeth – that rapid, sometimes noisy clack of your upper and lower teeth – is a minor, startling symptom that can ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

A collaborative team of researchers from the Donald Danforth Plant Science Center, the University of Florida, Gainesville and ...

UK analytics group Clarivate (NYSE: CLVT) has published its 2026 Drugs to Watch report, identifying 11 therapies it believes ...

Researchers develop an AI-based platform that integrates reaction data with catalyst performance for the design of new ...

Scientists are developing magnetically driven nanorobots that can actively navigate the bloodstream and deliver chemotherapy ...